SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

From textile recycling to autonomous vessels: The vision behind the Dream Team startups

ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”

Übermorgen Ventures: “The fundamentals of climate tech haven't changed”

Unit 8200 veterans raise $22 million Series A for real-time impersonation defense

Buzz

Most popular

Daily

Weekly

1

Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing

2

Check Point raises $1.75 billion, potentially eyeing AI expansion

3

Hapag-Lloyd eyes ZIM acquisition, workers push back

4

Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”

5

Nice puts Actimize up for sale at a $1.5-2 billion price tag

QuantHealth

4 stories about QuantHealth

Hila Karah Pitango Health

“The long-term opportunities in AI are immense for health-tech companies”

16.01.25|James Spiro, Elihay Vidal

Hila Karah, Managing Partner at Pitango HealthTech, joined CTech to share insights in the high-tech ecosystem.

Shoni Health Ventures outlines the landscape of opportunities and challenges in 2025

06.01.25|James Spiro, Elihay Vidal

CEO and Managing Partner Eran Lerer joined CTech to share insights on the year ahead and how HealthTech will be impacted.

Arnon Horev Orr Inbar

QuantHealth secures $2 million in funding from Accenture and other investors to deliver AI-powered clinical trial simulations

This announcement extends the Israeli startup’s recent $15 million Series A and comes on the back of the launch of its latest product, Katina, which provides clinical researchers with an AI-guided workflow that simulates hundreds of thousands of potential trial protocol combinations of patient groups, treatment parameters and different endpoints, to maximize the trial success probability

Arnon Horev Orr Inbar

QuantHealth announces $15 million Series A to use AI to enhance success of clinical trials

The Israeli startup’s AI platform predicts efficacy and safety of clinical trials to try and optimize trial design, and identify key response population